Human Biology Core, Project 10 of 10
人类生物学核心,项目 10(共 10 个)
基本信息
- 批准号:8138151
- 负责人:
- 金额:$ 6.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
One of the principal TORS goals is integration of new metabolic, genetic, and molecular cell biological data,
collected using multiple technologies in mouse models and human subjects, into a mechanistic understanding
of key aspects of obesity and type II diabetes. To advance this goal, we have formed a public-private research
partnership between the four TORS teams and an NIH-supported software and kinetic modeling company,
Integrative Bioinformatics Inc (IBI). IBI's software product, ProcessDB, is a tool for managing the development
of large scale quantitative mechanistic models and testing these simultaneously against multiple experimental
protocols using diverse measurement technologies. Dr. Phair, a former professor of biomedical engineering and
physiology at the Johns Hopkins School of Medicine, and his colleagues at IBI have many years of experience
with these techniques at levels of biological organization from whole human subjects to cultured cells. They
have published in many relevant areas including lipid and lipoprotein metabolism, endocrinology/nutrition, and
molecular cell biology. To reach the long term goal of an integrated mechanistic model of key aspects of the
physiology and pathophysiology of obesity, the modeling effort will draw from and contribute to each of the
TORS subprojects. Initially, however, we plan to focus on integration of information from two TORS teams:
Parks and Malloy (Burgess, Browning). To our knowledge, this will be the first integration of metabolic
information from well-established NMR and G.C/MS techniques in the same human subjects and patients.
Leveraging the unique strengths of both stable isotope methods is unprecedented. In years 02-05 we plan to
expand these inter-team projects to include: 1) Selection of informative human subjects (Cohen/Hobbs) from the
Dallas Heart Study to be analyzed using the GC/MS (Parks) and NMR (Malloy) technologies, and fitted to our
developing integrated model using constraints from known genetic defects in these individuals. 2) Development
of a parallel metabolic model for relevant aspects of mouse physiology and pathophysiology. This parallel
development will facilitate translation of basic research in the mouse model to testable hypotheses in human
subjects and patients. 3) Completion of a model of skeletal muscle metabolism including mitochondrial function
(Malloy), that can be combined with the hepatic model to produce an integrated model of two major
organs/tissues involved in the metabolic response to feeding and insulin. By putting the ProcessDB software on
each Pi's desktop, all TORS groups will have constant access to the developing integrated models and will be
able to propose modifications and additions to be tested. They can also add to the ProcessDB database new
experimental protocols and data. ProcessDB will thus serve as a focused mechanistic "knowledge environment"
for the TORS program, along the same lines as the signal transduction knowledge environment (STKE)
developed by AAAS/Science. (http://stke.sciencemag.org/).
主要TOR目标之一是整合新的代谢,遗传和分子细胞生物学数据,即
在鼠标模型和人类受试者中使用多种技术收集到机械理解
肥胖和II型糖尿病的关键方面。为了促进这一目标,我们成立了一项公私研究
四个TOR团队与NIH支持的软件和动力学建模公司之间的合作关系,
综合生物信息学公司(IBI)。 IBI的软件产品ProcessDB是管理开发的工具
大规模定量机械模型和同时测试这些模型
使用各种测量技术的协议。 Phair博士,前生物医学工程教授和
约翰·霍普金斯医学院的生理学和他在IBI的同事有很多年的经验
从整个人类受试者到培养细胞的生物组织水平上的这些技术。他们
已经在许多相关领域发表,包括脂质和脂蛋白代谢,内分泌学/营养以及
分子细胞生物学。达到关键方面集成机械模型的长期目标
肥胖的生理学和病理生理学,建模工作将借鉴并为每个
TORS子标题。但是,最初,我们计划专注于两个TOR团队的信息集成:
公园和马洛伊(伯吉斯,勃朗宁)。据我们所知,这将是代谢的第一个整合
来自同一受试者和患者的公认NMR和G.C/MS技术的信息。
利用这两种稳定同位素方法的独特优势都是前所未有的。在02-05年,我们计划
将这些团队间项目扩展到:1)从
达拉斯心脏研究将使用GC/MS(Parks)和NMR(Malloy)技术进行分析,并适合我们
使用这些个体中已知遗传缺陷的约束来开发集成模型。 2)发展
小鼠生理学和病理生理学相关方面的平行代谢模型。这个平行
开发将促进小鼠模型中基础研究的转化为人类可检验的假设
受试者和患者。 3)完成包括线粒体功能的骨骼肌代谢模型
(malloy),可以与肝模型结合使用,以产生两个主要模型
器官/组织参与对喂养和胰岛素的代谢反应。通过将ProcessDB软件放在
每个Pi的桌面,所有TOR组都将不断访问开发的集成模型,并且将是
能够提出要测试的修改和添加。他们还可以添加到ProcessDB数据库新
实验协议和数据。因此,ProcessDB将充当集中的机械“知识环境”
对于TORS程序,与信号转导知识环境(STKE)相同的线
由AAAS/Science开发。 (http://stke.sciencemag.org/)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD Harry LIVINGSTON其他文献
EDWARD Harry LIVINGSTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD Harry LIVINGSTON', 18)}}的其他基金
相似国自然基金
入核效应蛋白SidW的生化及生物学功能
- 批准号:32370196
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
正脊调节椎间盘力学微环境改善髓核退变的力学与分子生物学机制
- 批准号:82374615
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
代谢酶ACAT1核转位激活NF-κB发挥非经典生物学功能增强结直肠癌免疫治疗敏感性的机制研究
- 批准号:82303224
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
钙网蛋白“反转位”介导的力—生物学信号转导在低负荷压应力促进髓核自修复中的作用及机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
成熟RNA核降解的命运决定机制及生物学功能研究
- 批准号:32230022
- 批准年份:2022
- 资助金额:269 万元
- 项目类别:重点项目
相似海外基金
The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
- 批准号:
10404415 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别:
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2
解释 RAG2 中疾病相关基因组变异的 3D 方法
- 批准号:
10724152 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别: